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Patients  with  ﬁbromyalgia  were  treated  with cognitive  behaviour  therapy  tailored  for coping  with  stress  and pain.
Cognitive  behaviour  therapy  resulted  in better  life  control,  less  depression,  stress  and  fatigue.
Pain  intensity  was  not  affected  by  cognitive  behaviour  therapy  according  to this  protocol.
The  effects  of  therapy  were  maintained  and  enhanced  during  one  year  of  follow  up.
Behaviour  responses  to pain  are important  for  monitoring  and  not  only  for ratings  of pain.
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Background  and  aims:  Stress  has  been  pointed  out as  an  important  inﬂuential  factor  in the development
and  maintaining  of  the ﬁbromyalgia  syndrome  (FMS).  Since  stress  may  worsen  the  pain  experience,  the
development  of individual  strategies  for coping  with  stress  is  essential  to  reduce  the  impact  of  FMS  on
daily  life.  The  aim of the study  was to investigate  whether  a  group  based  stress  management  cognitive
behaviour  therapy  (CBT)  programme  could  inﬂuence  self-reported  stress,  wellbeing  and life  control,  as
well  as self-reported  pain  behaviour  in female  FMS  patients.
Methods:  48  female  FMS  patient  were  randomized  into  a cognitive  behaviour  therapy  treatment  group
(n =  24) and  a waitlist  control  group  (n =  24).  When  the 6 months  waitlist  period  was  over  the  control
group  received  the  same  CBT  programme.  This  allowed  two  analytical  approaches,  one  based  on  the
randomized  controlled  trial design  and  one  based  on a before-and-after  design  to  improve  the  statistical
power  of the  study.  Four  psychometric  instruments  were  used:  The  West  Haven-Yale  Multidimensional
Pain  Inventory  (three  parts,  MPI-1  to MPI-3),  the  Maastricht  Questionnaire,  the Everyday  Life Stress,
and  the  Montgomery-Åsberg  Depression  rating  scale  – self-reported.  Primary  outcome  was  the  MPI-1
dimension  ‘life  control’,  secondary  outcomes  were  the  MPI-1  dimensions  ‘interference’,  ‘affective  distress’
and  ‘support  from  spouses  or signiﬁcant  others’,  the  various  MPI-2  dimensions,  the  ‘general  activity  level’
in the MPI-3  dimension,  and  ‘vital  exhaustion’,  ‘stress  behaviour’,  and  ‘depression’.  The only tertiary
outcome  was  the  MPI-1  dimension  ‘pain  severity’.
Results: In the RCT  design  the  West  Haven-Yale  Multidimensional  Pain  Inventory  dimensions  ‘life
control’,  ‘interference  from  pain’,  ‘affective  distress’,  ‘support  from  spouses  or signiﬁcant  others’,  and
‘distracting  responses’  and  ratings  for depression  improved  in  the  treatment  group  as  compared  with the
control  group.  In the  before-and  after  design  these  improvements  were  maintained  and  enhanced  during
1-year  follow-up,  and  so  was  the  ‘vital  exhaustion’  and  ‘stress  behaviour’.  ‘Pain  severity’  was  rated  higher
after  the  intervention.
Conclusions:  Cognitive  behaviour  therapy  improved  the  life  control  in a female  population  with FMS.
Coping  behaviour  in  response  to chronic  pain  was  improved  at the  same  time and  in  spite  of  higher
DOI of refers to article: http://dx.doi.org/10.1016/j.sjpain.2015.08.005.
Abbreviations: ACR, American College of Rheumatology; FMS, ﬁbromyalgia syndrome; CBT, cognitive behaviour therapy; MADRS-S, Montgomery-Åsberg Depression Rat-
ng  Scale – self-reported; MPI, Westhaven-Yale Multidimensional Pain Inventory; MPI-S, Westhaven-Yale Multidimensional Pain Inventory Swedish version; RCT, randomized
linical trial.
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subjective  ratings  of  pain.  Positive  effects  were  seen  on depression,  vital  exhaustion  and stress  behaviour.
The  effects  of  therapy  were  maintained  and  enhanced  during  the  follow  up period.  It appears  that  women
with  FMS  after  the  CBT  treatment,  according  to this  protocol  obtained  tools  leading  to better  acceptance
of their  disorder.
Implications:  FMS  is  a disorder  with  great  therapeutic  challenges.  Total  abolishment  of  pain symptoms
is extremely  difﬁcult  or impossible  to achieve.  Thus,  the development  of  individual  strategies  for  coping
with pain  is  essential  to reduce  its impact  on  daily  life.  Since  stress  may  worsen  the  pain  experience,
coping  with  stress  might  be a  promising  route  to accomplishing  that  goal.  In evaluations  of interventions
for pain  it  is important  to monitor  the  effect  on behaviour  responses  to pain  and  not  only  ratings  of  pain
itself.
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. Introduction
The ﬁbromyalgia syndrome (FMS) is a chronic pain disorder, for
hich classiﬁcation criteria were established by the American Col-
ege of Rheumatology (ACR) in 1990 [1]. The two major criteria are
 history of widespread pain for three months or more, and ten-
erness in at least 11 out of 18 deﬁned tender points. In addition
o pain, most FMS  patients suffer from fatigue, sleep disturbances,
ognitive problems and a variety of symptoms such as backache,
ausea, diarrhoea, constipation [2,3], resulting in disability and
educed quality of life [4].
Co-morbidity with psychiatric diagnoses, such as depression
nd anxiety disorders, is common. Approximately one out of three
MS  patients have a depression diagnosis. FMS  has a female pre-
onderance, female to male ratio 10:1 [5,6].
Evidence has been presented that FMS  has its origins in the
entral rather than the peripheral nervous system or the mus-
uloskeletal system [7–9]. There is also evidence that FMS  is a
tress-related disorder [9–11]. A strong relationship to stress-
elated morbidity, low levels of serotonin, and perturbed pain
rocessing peptide levels found in FMS  patients, have been for-
arded as evidence [12–14].
Stress involves the individual’s mobilization of resources to deal
ith threat and challenge. The stress concept includes both stressor
load/challenge) and response. There is no universally accepted def-
nition of stress. However, a useful and widely adopted deﬁnition
s to regard stress as a process in terms of external challenges, cop-
ng resources and perception of coping resources, and the dynamic
nterplay of these over time [15,16]. The formulation has its origin
n the conceptualization proposed by Lazarus and Folkman [17].
his deﬁnition of stress provides a useful framework for the present
tudy.
According to a bio-psycho-motor model [18] at least three
ehaviour subsystems: communicative pain behaviours, protec-
ive pain behaviours, and social response behaviours, are integral
omponents of pain. The bio-psycho-motor model is an improve-
ent as compared to earlier models because its emphasis on
ehaviours as central to the distress of chronic pain. It implies a
hain of events and consequences: tissue damage – pain sensation
 reﬂective/automatic and operant pain behaviours – functional
mpairment and distress – reduced activities – disability. When
ain leads to disabling consequences in a person’s everyday life,
he pain sensation per se – or even the presence of tissue damage –
ay  not be the main determining factor. Therefore, in pain assess-
ent and treatment, focus must be placed on functional analyses
f the resulting behaviours: communicative, protective, and social
esponsive. Both communicative (e.g. facial expressions and voca-
izations) and protective (withdrawal, escaping, holding, rubbing,
ostural adaptations) can be viewed as reﬂexive and automatic.The magnitude and expressiveness of such responses are
lso inﬂuenced by social and cultural norms, as well as the
fﬂicted person’s beliefs, fear, and expectations. Social responses tohed  by  Elsevier  B.V.  This is  an  open  access  article  under  the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
communication of pain may  play a role in the development and
maintenance of pain-related disability [18], independent of the
pain level per se, by selective reinforcement of pain behaviours.
Since dysfunction may  arise in behavioural systems separate from
pain sensation, treatments targeting pain sensation might not
always yield the best outcomes. On the contrary, disability may
be reduced in the absence of reduction in pain.
A CBT manual, developed on a theoretical framework with a
focus on affective and behaviour consequences of pain, as well as
cognitive and behaviour strategies for coping with pain and stress,
was used in the present study. The prime hypothesis was  that
this version of CBT in female FMS  patients inﬂuences the MPI-1
dimension ‘life control’. The secondary hypothesis was  that CBT
inﬂuences the MPI-1 dimensions ‘interference’, ‘affective distress’
and ‘support from spouses or signiﬁcant others’, the various MPI-
2 dimensions, the ‘general activity level’ in the MPI-3 dimension,
and ‘vital exhaustion’, ‘stress behaviour’, and ‘depression’. The ter-
tiary hypothesis was that CBT inﬂuences the MPI-1 dimension ‘pain
severity’.
2. Material and methods
2.1. Study population
The study was  performed in a municipality in central Sweden
with approximately 22,000 inhabitants in 2001–2003. The study
population was  recruited by advertising in the local daily news-
paper and an information meeting with the local branch of the
Fibromyalgia Patient Association.
Responding female women with FMS  were invited to an exam-
ination at the coordinating primary health care centre. Inclusion
criteria were age 18–64 years, being Swedish-speaking, and fulﬁl-
ment of the 1990 ACR criteria [1] (generalized pain for more than
three months, distributed in all four body quadrants, and at least
11 tender points in typical locations). Exclusion criteria were major
psychiatric or somatic disease, and substance abuse.
Information was sought on duration of generalized pain as well
as time since possible FMS  diagnosis. Tender points were assessed
manually by ﬁnger top pressure of 40 N/cm2 by one physician (BK).
History of severe psychiatric or somatic disease was  obtained from
medical records, in addition to information from the patient dur-
ing the screening examination. No formal testing of psychological
disorders or symptoms was  done during this examination. A phy-
siotherapist experienced in FMS  tender point assessment validated
the diagnostic procedure.
Among the 54 female patients recruited, six patients were
excluded after these procedures. Two did not fulﬁl the diagnos-
tic criteria, two  had a serious mental disorder, and two  declined
participation after receiving further information about the study.
The remaining 48 women agreed to participate and were using a
random block design allocated into two  groups, group 1 (n = 24) and
group 2 (n = 24). The randomization was performed with the SAS
B. Karlsson et al. / Scandinavian Journal of Pain 9 (2015) 11–21 13
Potential study population
n=54
Final study population
Inclusion  cri teri a not fu lfille d n=2
Exclusion  criteria  fulfilled  n=2
Declined participation n=2
n=48
Group 1 n=24
CBT intervention group
Group 2 n=24
Wait-list group 
CBT after 6 months
1st measurement
Treatment period
Participated n=23
No participation  n=1
(severe depression)
n=23 n=24
2nd measurement
Treatment period
Participated n=21
No participation  n=3
Moved away=1
Other therapy=1
Family reasons=1
One year follow up
3rd measurement
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n=22
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unction ‘ranuni’ that produces random numbers with equal distri-
ution, i.e. all numbers appear with the same probability. According
o this design for every four consecutive patients two  were ran-
omly allocated to group 1 and the remaining two  were allocated
o group 2. The allocations were indicated on paper sheets and put
n sealed envelopes with a patient serial number on the outside. The
heet furthermore had a disturbing text on the backside to prevent
eading the allocation through the envelope. The envelopes were
tored with the study monitor. When patients were included in the
tudy they were given a serial number, the corresponding serial
umber envelope was opened and the patient allocation was noted
n the study chart.
.2. Study design
The study was designed as a two-arm parallel group RCT, with
roup 1 as intervention group and group 2 as control group (Fig. 1).
he intervention group received the CBT treatment and the con-
rol group was wait-listed. When the RCT was concluded, group 2,
he previous control group, received the same CBT treatment as the
roup 1. A before-and-after treatment design was then performed
or the two groups together (increasing the number of treated sub-
ects from 24 to 48), a standard procedure in RCTs with small study
opulations.
The patients’ local physicians were informed about the study
nd were responsible for the every-day care of the patients. There study population.
were no restrictions in changing medication or other treatment
modalities. However all such changes were assessed and docu-
mented in the study protocol. All participants gave oral informed
consent to participation, standard procedure at the time, and the
trial was  performed in accordance with the Helsinki declaration.
The Research Ethics Committee at Uppsala University approved the
study.
2.3. Data collection
Data was collected on three occasions for group 1 and four occa-
sions for group 2 (Fig. 1). The ﬁrst measurement was performed
after randomization but before the treatment or wait list period
began. Measurements were then made after the 6 and 12 months in
group 1 and after 6, 12 and 18 months in group 2, For examination
and data collection the patients attended the study coordinating
primary health care centre between 8:00 and 10:00 a.m. For pre-
menopausal women  all measurements were performed 9–14 days
after the ﬁrst day of the last menstrual period to avoid interfer-
ence regarding endocrine variables [19]. In order to obtain reliable
self-reported data, it was  emphasized that the study would have
no consequences for disability or sick-leave compensation.2.3.1. Medical examination data
At baseline an extensive history-taking and physical exami-
nation was  performed by one of the authors (BK). At baseline
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nd at each examination anthropometric data, including height,
eight, waist and hip circumference, was obtained. Furthermore,
nformation was sought on menstrual status, i.e., whether the par-
icipant was pre-menopausal, menopausal or post-menopausal,
nd whether the patients were using hormone replacement ther-
py. Co-morbidity, current medication, and other treatments, such
s physiotherapy, were registered. Tender points were re-evaluated
t the last examination. No formal semi-structured psychiatric
xamination was performed. However, an experience general prac-
itioner performed the medical interview and a detailed scrutiny
f all available medical records including medical records from
omatic and psychiatric clinics was done with the aim to ﬁnd obvi-
us psychiatric illness.
.3.2. Socio-economic data
Information on marital status, educational level, whether they
ere in gainful work (employed or students), the extent of their
orking hours, and if they were granted a disability pension,
ull time or part-time was obtained. Smoking habits, alcohol con-
umption and physical activity was measured according to WHO
tandards [20].
.3.3. Psychometric data
At baseline information on important life events was obtained
ith the questionnaire Experienced important life events,  an instru-
ent developed by one of the authors (UMA) for patients with FMS
21], consisting of 11 questions regarding important life events
uring childhood and adolescence, 21 questions about impor-
ant life events during the 10 years before diagnosis of FMS, and
he same 21 questions the year before the baseline examination.
ossible responses were ‘strongly negative’ (=−2), ‘notably nega-
ive’ (=−1), ‘hardly negative at all’ (=0), or ‘positive’ (=1). A score
as obtained by summing the corresponding items for each time
eriod (range from −22 to 0 for childhood, range from −31 to
1 for last 10 years, and range from −18 to +1 for the last year).
his instrument has previously been used in other patients with
MS  [21], patients with social phobias [22] and patients with
igraine [23].
At baseline and at each follow up examination data were
btained from four other psychometric questionnaires. The ques-
ionnaires were ﬁlled in either on site or were taken home by the
atients to be answered and mailed back.
The West Haven-Yale Multidimensional Pain Inventory (MPI) [24]
s a self-report instrument for comprehensive assessment of indi-
iduals with chronic pain. It is based on cognitive-behaviour theory
nd intended for use in multi-axial assessment of pain that inte-
rates medical, psychosocial and behaviour data. Responses were
iven on seven-point scales (range 0–6). The instrument has been
ranslated and tested in many languages, including a Swedish
ersion (MPI-S) [25]. The reliability and factor structure for the
odiﬁed Swedish version have been found satisfactory including
nternal consistency and construct validity across gender [26]. Fur-
hermore, it has been used in a Swedish study on musculoskeletal
ain and return to work [27].
The ﬁrst part of the MPI-S instrument (MPI-1) ‘psychosocial
imension’ measures the perceived impact of pain on the of the
atient’s life (‘pain severity’, ‘interference’, ‘life control’, ‘affective
istress’ and ‘support from spouses or signiﬁcant others’). The sec-
nd part (MPI-2) the ‘behaviour – signiﬁcant others dimension’
easures responses from others to the patient’s communication of
ain (‘punishing’, ‘solicitous’ and ‘distracting’). The third part (MPI-
) the ‘behaviour – activities dimension’. It measures the extent to
hich patients participate in common daily activities (‘household
hores’, ‘outdoor work’, and ‘leisure activities’ summed up in a ‘gen-
ral activity level’). MPI-3 is not included in the MPI-S instrument.rnal of Pain 9 (2015) 11–21
However, in this study the ‘general activity level’ was estimated
according to the original MPI  instrument.
The Maastricht Questionnaire [28,29] was  used to measure
‘vital exhaustion’ (fatigue). This instrument is extensively used
to evaluate treatment effects, for instance in Swedish studies on
cardiac disease [30–32]. Responses to the 19 items were given
on three-point scales (0–2), total range 0–38, high scores indicat-
ing a high degree of ‘vital exhaustion’. A ﬁve-point difference has
been claimed to be of major inter- or intra-individual signiﬁcance
[28,29].
The Everyday Life Stress instrument was used to assess the level
of self-rated ‘stress behaviour’ [33,34]. It has two  major themes:
time urgency/impatience, and easily aroused irritation/hostility.
Responses to the 20 items were given on four-point scales (0–3)
giving a total score of 0–60, higher scores indicating more stress-
ful reactions. Internal consistency is high (Cronbach’s alpha = 0.90)
[35], as is test–retest reliability (0.90) [35]. The rationale for the
use of this instrument is that negative emotions are related to, and
may  worsen, the experience of pain, for instance in FM patients, and
may  also trigger and reinforce avoidance behaviour. The Everyday
Life Stress scale assesses negative emotional reactivity in the form
of anger/irritation/impatience – affects often experienced by pain
patients. Thus, a change in such emotions is hypothesized to be
related to more adequate coping and to decreased pain behaviour
patterns. Furthermore, negative affectivity was  a main focus in the
intervention.
The Montgomery-Åsberg Depression Rating Scale – self-reported
(MADRS-S) is a validated instrument for evaluating treatment
effects on ‘depression’ symptoms. It is a self-reported scale based
on evaluations of the past three days regarding nine issues: mood,
feelings of unease, sleep, appetite, ability to concentrate, initiative,
emotional involvement, pessimism and zest for life on seven-point
scales (range 0–6 individual items, total range 0–54) [36–38]. The
consistency of the MADRS-S is satisfactory with Cronbach’s alpha
0.84 [38]. As sleep disturbance is an important feature the item
‘sleep’ in the MADRS-S instrument, it will be analyzed separately.
2.4. Intervention
The CBT stress management programme is described in detail
in the electronic supplementary material. Brieﬂy, the intervention
consisted of twenty CBT sessions during a 6-month period. The
women were allocated into treatment subgroups with 5–7 women
in each, receiving one group session a week, with 3-hour duration.
When the 20 sessions were completed, three CBT group booster
sessions were given during the next six months, each with three
hours’ duration. Two  psychologists trained in CBT provided the
treatment. To secure continuity, each subgroup had the same ther-
apist throughout the programme. The psychologists took no part
in planning or evaluation to avoid interference with the results of
the study. Median attendance rate was 93%; inter quartile range
91–100%.
Quality assurance of the delivery of treatment was achieved
through continuous supervision by one of the co-authors (GB).
Treatment sessions were also monitored by patients’ subjective
evaluations of pain, stress and well-being with visual analogue
scales (1–100 mm),  which gave an indication of the feasibility and
attractiveness of the treatment from the patients’ perspective.
The overall goal of the CBT was to develop emotional,
behavioural, and cognitive coping strategies for dealing with
stress and pain. Treatment components included knowledge, self-
monitoring, behavioural skills training, cognitive restructuring, and
life value issues. Life values are important determinants of motiva-
tion for behaviour change, and for the individual’s own purpose and
long-term goals and maintenance. Dealing with life values can be
subsumed under ‘cognitive restructuring’.
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was a signiﬁcant increase in group 1 as compared with group 2
for the ‘distracting’ responses score (p = 0.03). There were no sig-B. Karlsson et al. / Scandinav
The therapeutic material included case illustrations, audio-
isual material, readings, hand-outs, exercises, and thematic
iscussions. Items of special importance, such as anxiety, exhaus-
ion, self-esteem, and marital distress were discussed [33].
omework assignments were applied between each session and
ncluded self-monitoring by simple diaries as well as a booklet with
ehavioural and cognitive exercises.
Each session had an agenda and a speciﬁc theme. The current
heme was discussed and elaborated, and new themes and issues
ere introduced, building on previous discussions. A short relax-
tion technique (Jacobsen’s progressive relaxation technique) was
aught [39].
.5. Statistical analysis
The statistical analyses were conducted using the SAS software,
ersion 9.3 [40]. Partial non-response (missing data in returned
uestionnaires) was on average 0.6% with a maximum in individual
ariables of 1.1%. Simple differences between groups in continu-
us variables were tested with Student’s t-test, and differences in
roportions with the chi-square test.
Two analytical designs were used, both based on the intention-
o-treat approach. The ﬁrst, a classical RCT, was  based on a
raditional two-arm parallel group design with group 1 serving
s intervention group and group 2 as control group. The second
esign was based on a before-and-after treatment approach in
oth groups after intervention. The purpose with the two designs
as to use data more efﬁciently and to crosscheck results from
he two designs. Primary outcome was the MPI-1 dimension ‘life
ontrol’, secondary outcomes were the MPI-1 dimensions ‘interfer-
nce’, ‘affective distress’ and ‘support from spouses or signiﬁcant
thers’, the various MPI-2 dimensions, the ‘general activity level’
n MPI-3 dimension, and ‘vital exhaustion’, ‘stress behaviour’, and
depression’. The only tertiary outcome was ‘pain severity’ in the
PI-1.
No a priori power analysis was made, but a post hoc analysis was
one, based on the RCT design covering the ﬁrst 6 months. For the
rimary outcome ‘life control’ the power to detect the differences
ound between group 1 and 2 was 90% given the size of the study
opulation, contrasting to the power of 38% found for the one of
he secondary outcome ‘stress behaviour’.
The RCT analyses were performed with the SAS procedure
General Linear Model’ (linear regression) and its option Repeated
easures Analysis of Variance. The baseline and ﬁnal levels of the
utcome variable were used as the dependent variables, and the
roup assignment as the independent variable. The repeated meas-
res analysis does not assume uncorrelated measures across time.
he before-and-after analyses were performed accordingly, with
roups 1 and 2 pooled and group assignment used as covariate
variance reducer).
The analyses were performed in two steps. First, preliminary
nalyses were performed with outcome as the dependent vari-
ble and the group variable and each of the possible determinants,
ne at a time, as independent variables. Signiﬁcant variables in
he preliminary analyses were entered into the ﬁnal multivariate
nalyses.
The ﬁnal analyses of the RCT design were performed as mul-
ivariate analyses as described above, but in addition, the initial
utcome level (to adjust for bias due to different initial levels
etween groups) and variables affecting outcome, other than the
reatment groups and initial outcome level, identiﬁed in the pre-
iminary analyses, were entered as covariates. The latter were
being in gainful work’, ‘waist/hip ratio’, ‘smoking habits’, ‘alco-
ol consumption’, ‘duration of generalized pain’, ‘number of tender
oints’, ‘menstrual status’, ‘important childhood and adolescence
xperiences’, and ‘therapist’. To avoid model overload, backwardrnal of Pain 9 (2015) 11–21 15
elimination of non-signiﬁcant variables was used. Also stepwise
entrance of independent variables was  used but gave results almost
identical to backward elimination. For this reason the latter was
used.
The ﬁnal analysis in the before-and-after treatment design was
simpler, since both groups served as their own controls. The only
covariates used were group assignment and initial outcome level.
No signiﬁcant interactions were found between group assignment,
outcome variables and time. All tests were two-tailed. The level of
signiﬁcance in the preliminary analyses was  set at p < 0.10 and in
the ﬁnal analyses models at p < 0.05.
3. Results
3.1. Characteristics of the study population
Characteristics of the study population are shown in Table 1.
Mean age was 49 years, about 85% were married, 25% had manda-
tory education only, less than half were in gainful work, mean
body mass index was  29, and approximately one out of ten were
smokers. The average alcohol consumption was  5 g of pure alco-
hol during the last week, and the mean physical activity score
on a four-point scale was  1.9. The patients had on average a
pain history of more than ten years, more than ﬁve years with
a ﬁbromyalgia diagnosis, and on average 16 out of 18 diagnos-
tic tender points. About 40% were on anti-depressants, and more
than half were on intermittent or continuous analgesics, slightly
less than half were on hormone replacement therapy. There were
no signiﬁcant differences between the two groups in these vari-
ables. Two CBT therapists gave treatment in group 1versus one in
group 2.
No signiﬁcant outcome differences were observed between the
assessments of the two treatment psychologists. During the study,
10 participants were started on anti-depressant medication and 6
discontinued. Taking or changing the intake of anti-depressants did
not inﬂuence the outcome of this study. No non-pharmacological
treatment for FMS  by us or by others was administered during
the study period. There were no differences in number of tender
points.
3.2. Outcome in the two-arm group parallel design (RCT)
Outcome variables of the RCT design are presented in Table 2,
with crude levels and levels adjusted for potential covariates and
baseline differences of the outcome variables in group 1 before-
and-after treatment and the corresponding points in time for group
2 before-and-after the wait list period.
In the ‘psychosocial dimension’ scales (MPI-1), ‘life control’
score increased in group 1 from 3.15 to 3.62, while it decreased in
group 2 to 2.86 (p = 0.01), ‘pain severity’ score increased from 3.61 to
4.20 in group 1 and decreased to 3.37 in group 2 (p = 0.02) and ‘inter-
ference’ score increased from 3.70 to 4.07 in group 1 and decreased
to 3.45 in group 2 (p = 0.04). ‘Affective distress’ score declined from
2.75 to 2.20 in group 1 as compared to a rise to 3.08 in group 2
(p = 0.01). The ‘support from spouses or signiﬁcant others’ score
increased from 3.64 to 3.92 in group 1 as compared to a decline
to 3.03 in group 2 (p = 0.03).
In the ‘behaviour – signiﬁcant others dimension’ (MPI-2) thereniﬁcant differences between groups in the ‘behaviour – activities
dimension’ (MPI-3). ‘Depression’ score decreased in group 1 while
it increased in group 2 (p = 0.02). For the ‘sleep’ score in MADRS-S
the differences in trend between groups were non-signiﬁcant.
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Table 1
Characteristics of the study population.
Group 1 Group 2
n Mean (SD) or % n Mean (SD) or %
Age at baseline, years 24 48.3 (11.50) 24 48.8 (6.50)
Married, % 20 83.3 22 91.7
Mandatory education only, % 5 20.8 8 33.3
In  gainful work, % 7 29.2 12 50.0
Body  mass index 28.5 (5.81) 29.0 (4.34)
Waist-hip circumference, ratio 0.82 (0.07) 0.84 (0.07)
Smokers, % 3 12.5 2 8.3
Snuff-takers, % 1 4.2 2 8.3
Alcohol, grams during the last week 4.6 (5.00) 6.3 (6.33)
Physical activity, score 1.88 (0.34) 1.96 (0.37)
Duration of generalized pain, years 10.7 (6.46) 12.0 (7.06)
Time  with ﬁbromyalgia diagnosis, years 5.3 (4.67) 5.0 (4.01)
No.  of tender points 16.0 (2.56) 15.5 (2.30)
On  analgesic drugs, continuously or intermittent, % 16 66.7 16 66.7
Anti-depression medication, % 8 25.0 13 54.2
Pre-menopausal, % 9 37.5 9 37.5
Hormone replacement therapy, % 13 54.2 9 37.5
Co-morbidity
Hypertension, % 6 25.0 2 8.3
Asthma cortisone treatment, % 4 16.7 4 16.7
Diabetes, % 2 8.3 1 4.2
Thyroid disorder, % 4 16.7 6 25.0
Experienced important life event, score
During childhood and adolescence 7.3 (5.90) 4.0 (4.67)
During  the 10 years before the ﬁbromyalgia diagnosis 10.9 (9.74) 10.5 (7.04)
During  the year before randomization 4.8 (4.24) 5.4 (5.02)
CBT  therapist
A, % 13 54.2 0 –
B,  % 11 45.8 24 100.0
Median interval inclusion-therapy start, months 1.2 8.5
3
p
a
(
n
t
T
E
P
a
aMedian interval therapy start-evaluation, months
Median interval therapy start-follow up, months 
.3. Outcome in the before-and-after treatment design
Outcome variables for the before-and-after treatment design are
resented in Fig. 2. ‘Life control’ improved almost 20% during ther-
py and follow up (p < 0.01), ‘affective distress’ improved by 15%
p < 0.05), while the ‘interference’ and ‘support from spouses or sig-
iﬁcant others’ showed no tendency towards change. ‘Vital exhaus-
ion’ improved by 12% (p < 0.01), ‘stress behaviour’ improved by 15%
able 2
ffect during 6 months from baseline of treatment in parallel group design on variable
-values refer to trends across time, adjusted for baseline differences in outcome variab
lcohol consumption, duration of generalized pain, number of tender-points, menstrual s
re  mean (SD). Adj = adjusted values.
Intervention group 
Before treatment After treatment 
Crude Adj Crude Adj
Psychosocial dimension (MPI-1)
Pain severity 3.85 (0.80) 3.61 3.88 (1.05) 4.
Interference 4.04 (0.57) 3.70 4.05 (0.85) 4.
Life  control 3.13 (0.89) 3.15 3.51 (1.03) 3.
Affective distress 3.12 (0.62) 2.75 2.94 (0.69) 2.
Support 3.63 (1.62) 3.64 3.42 (1.52) 3.
Behaviour – signiﬁcant others dimension (MPI-2)
Punishing responses 1.05 (1.22) 1.18 1.37 (1.72) 1.
Solicitous responses 3.26 (1.52) 2.58 3.02 (1.47) 2.
Distracting responses 2.90 (1.41) 2.91 2.70 (0.97) 3.
Behaviour – activity dimension (MPI-3)
General activity level 2.99 (0.69) 2.92 2.80 (0.62) 2.
Vital  exhaustion 24.92 (6.71) 23.21 22.04 (5.14) 20.
Everyday life stress 20.96 (8.75) 21.28 18.63 (9.13) 21.
MADRS-Sa 17.38 (8.25) 15.21 14.75 (7.96) 13.
a MADRS-S, The Swedish version of the Montgomery-Åsberg Depression Rating Scale –6.3 4.9
12.1 12.3
(p < 0.01). Total ‘depression’ score improved by 20% (p < 0.01), while
differences in the ‘sleep’ component were non-signiﬁcant. For
‘pain severity’ there was  a non-signiﬁcant trend towards improve-
ment. For l´ife control,´ ‘affective distress,´ ‘vital exhaustion’, ‘stress
behaviour’ and ‘depression’ there were an improvement not only
during the six-month trial period, but also during the six-month
follow up. There were no effects of analgesic, antidepressant or
hormone replacement therapy in any of the designs.
s in Multiple Pain Inventory, Vital exhaustion, Everyday life stress and MADRS-S.
les, and of the inﬂuence of being in gainful work, waist/hip ratio, smoking habits,
tatus, importance of childhood and adolescence experiences and therapist. Values
Control group p
Before wait list After wait list
 Crude Adj Crude Adj
20 3.38 (0.92) 3.61 3.67 (0.75) 3.37 0.02
07 3.37 (1.09) 3.70 3.43 (0.82) 3.45 0.04
62 3.18 (0.95) 3.15 2.94 (1.18) 2.86 0.01
20 2.83 (0.79) 2.75 2.92 (0.57) 3.08 0.01
92 3.65 (1.60) 3.64 3.48 (1.48) 3.03 0.03
38 1.30 (1.45) 1.18 1.00 (1.25) 0.90 NS
71 2.87 (1.67) 2.58 2.76 (1.49) 2.15 NS
22 2.92 (1.73) 2.91 2.77 (1.61) 2.30 0.03
83 2.92 (0.50) 2.92 2.85 (0.67) 2.82 NS
96 21.50 (6.52) 23.21 21.71 (6.80) 22.79 NS
11 21.92 (11.76) 21.28 20.92 (8.67) 17.94 NS
09 13.04 (7.64) 15.21 14.79 (6.37) 16.45 0.02
 self-reported.
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 1 (n =
4
4
mFig. 2. Combined results according to the before and after treatment in group
. Discussion.1. RCT and the before-and-after design
The results from the RCT and the before-and-after treat-
ent designs were fairly consistent. Positive effects in the RCT 24) and before and after treatment in group 2 (n = 24), altogether 48 patients.
for ‘life control’, ‘affective distress’, and ‘depression’ were also
seen in the before-and-after treatment design during the treat-
ment period and tended to be further enhanced at follow up 12
months after start of CBT treatment. The subjective impairment
in the RCT for ‘pain severity’ and ‘interference’ from pain was
not observed in the before-and-after treatment design, nor were
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erceived ‘support from spouses or signiﬁcant others’ or ‘distract-
ng’ responses.
‘Vital exhaustion’ and ‘stress behaviour’ ratings were reduced
or both groups in the RCT but the difference between groups
ere non-signiﬁcant. In the before-and-after treatment design a
mall but signiﬁcant improvement, enhanced during the follow up
eriod, was seen, possibly an effect of higher statistical power in the
efore-and-after design than in the RCT, but this may  also reﬂect
hat changes of long established behaviour may  take some time to
e implemented.
In the RCT, ‘pain severity’ and ‘interference’ from pain both
ncreased more in the intervention group than among controls,
hile ‘life control’ showed the opposite pattern. A possible expla-
ation might be that the women reﬂected more on their pain and
he impact of it, in line with the treatment goals of self-monitoring
imed to increase the awareness of ones’ own reactions, and at
he same time they gained more control over their lives and pain
ehaviour in general. Since the CBT programme focused on stress in
elation to pain, and included diaries and self-monitoring, women
ight have increased their awareness of pain sensations. However,
he results indicate that the negative impact of pain in daily life
ecreased.
The ﬁndings are consistent with the aim of the CBT, focusing on
tress behaviour and general well-being in favour of techniques of
irect pain reduction. The improvement towards more adequate
ain behaviour strategies and well-being is in line with earlier
xperiences from CBT treatment, for instance in coronary patients
here differences between CBT treated and non-treated patients
ere maintained and enhanced up to seven years after the conclu-
ion of the treatment period [34].
The changes found in the present study were numerically rather
mall and may  not always have been considered clinically signiﬁ-
ant in previous studies. However, given that these patients often
ave suffered from their disorder for years, even small changes
ay  be interpreted as beneﬁcial, and even more so if the positive
hanges from various variables co-operate and tend to persist for a
ong time after therapy is concluded.
.2. Previous studies
The intervention in this study was based on a group based stress
anagement CBT, tailored for treatment of patients with cardiovas-
ular diseases has proven to be very effective in reducing recurrent
eart attacks [41].
The implications of CBT as a treatment facility in ﬁbromyalgia
s reﬂected, apart from the present study, in a meta-analysis of
sychological treatments for ﬁbromyalgia made by Glombiewski
t al. [42]. The inclusion criterion in the meta-analysis was  that at
east three out of ﬁve outcomes (pain, sleep, depression, catastro-
hizing, and functional status) were used to evaluate the efﬁcacy
f the treatment. They identiﬁed 23 eligible studies including 30
sychological treatment conditions and 1396 patients. Of these
ight used CBT as one treatment modality [43–50]. They drew
he conclusion that psychological treatment in ﬁbromyalgia may
e effective interventions and the effects comparable to those
n short-term drug treatments. The stable long-term effects and
arger effect size of CBT and other psychological interventions
ndicate that these treatments are more favourable than other
on-psychological treatments, which only give short-term effects
51]. When patients attribute positive changes to their own  effort,
he effects are usually maintained better than effects attributed to
xternal causes, such as medication [51–54].Acceptance and commitment therapy, one of the recent devel-
pments of CBT was studied in a randomized clinical trial by
icksell et al. [55]. Pain-related functioning and psychological
exibility improved in spite of no reduction in pain intensity. Inrnal of Pain 9 (2015) 11–21
a Cochrane Collaboration review including 23 studies with 2031
patients the effects of CBT on FMS  was  evaluated. It was concluded
that CBT, as compared to control treatments, might to some extent
reduce pain, negative mood and disability at the end of treatment
and after follow-up. Pain was rated with a 6.3% absolute improve-
ment. However among the ten studies with an intention-to-treat
design only four showed a signiﬁcant result [56].
4.3. Therapeutic implications
Thus, in chronic pain treatment, assessment of beliefs,
appraisals, and coping strategies are prerequisites for optimi-
zing a treatment programme [51,57]. The cognitive-behaviour
framework implies a treatment focus on changes of maladaptive
behaviour and cognitive coping in the direction of a more adaptive
one, and an increase in self-efﬁcacy and sense of control. Research
ﬁndings indicate that a treatment approach focusing on develop-
ment of strategies for coping with pain may  result in a decrease of
the intensity of the pain experience, as well as reduced psycholog-
ical distress [51].
Given that total abolishment of pain symptoms is extremely dif-
ﬁcult or impossible to achieve, interventions should focus on the
effects of pain on daily function and quality of life, and thereby give
the patients more satisfaction and possibly a reduction of the pain
experience. Thus, the development of individual strategies for cop-
ing with pain is essential to reduce its impact on daily life. In order
to achieve increased self-efﬁcacy and sense of internal control over
one’s life, the individual’s own  motivation (reason and need) for
change should be an important target for intervention. Since stress
may  worsen the pain experience, coping with stress might be a
promising route to accomplishing that goal.
It is well known that psychological and social factors inﬂuence
perception and perpetuation of chronic pain [58,59]. It has been
suggested that patients with FMS  are more affected by normal daily
stress than healthy individuals [11,60]. FMS  patients may be caught
in a vicious circle where pain and negative emotions may  lead to
fears of more pain. Cognitive factors, such as intrusive thoughts
(‘catastrophizing’), may  act as discriminative stimuli for avoid-
ance behaviours [58]. The risk of developing behaviour patterns
that gradually decrease activity and daily function is particularly
great when there is no known cause of the pain symptom [57–59].
Intrusive thoughts are powerful triggers for avoidance behaviour
patterns, and may  be reinforced by increased attention from sig-
niﬁcant others and health care staff [61]. It has been shown that
sense of self-efﬁcacy, i.e., belief in one’s ability to act and inﬂuence
outcomes of one’s actions, increases as intrusive thoughts diminish
[51,62].
4.4. Strengths and limitations
The strengths of the present study include that only validated
instruments were used for outcome analyses, most of which have
been used extensively in previous studies. The intervention CBT
protocol used in this study has been validated and used in a number
of previous studies [34,41,63]. Furthermore, the participation rate
was high, no differences in outcome attributable to which of the two
CBT therapists that gave the therapy, and the CBT therapists were
not involved in the outcome assessments. The monitoring of the
study was  excellent, resulting in very small data loss. The statistical
analysis was  state of the art, and the results from the two  analyt-
ical designs were fairly consistent. Moreover, in the RCT potential
outcome affecting variables other than the CBT were taken into
account, optimizing analytical precision and conclusion validity.
This was not necessary in the before-and-after design, since the
subjects were their own  controls.
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One further strength is that the data for pre-menopausal women
ere collected 9–14 days after the ﬁrst day of the last menstrual
eriod to avoid interference regarding endocrine variables [19]. In
rder to obtain reliable self-reported data, it was emphasized to the
articipants that the aim of the treatment was not to push them to
 higher level of working capacity, but to increase their well-being
nd quality of life.
The limitations of the study include that the study population
as fairly small. However, we had so many participants in the study
s was deemed feasible for ﬁnancial and logistic reasons. No a pri-
ri power analysis was  made, but a post hoc analysis was done,
howing that the study population was large enough for the main
ypothesis testing. The study population was not necessarily rep-
esentative of FMS  patients in the general population, even though
he vast majority of FMS  patients in Sweden are treated in general
ractice. The patients’ own physicians carried out the usual patient
are with no restrictions in terms of changing medication or other
reatment modalities. However, all such changes were registered
n the study protocol. Another possible limitation might be that no
peciﬁc measures examining pain appraisal were included, allow-
ng examination of for instance pain catastrophizing and hyper
igilance.
. Conclusion
Cognitive behaviour therapy improved the life control in a
emale population with FMS. Coping behaviour in response to
hronic pain was improved at the same time and in spite of higher
ubjective ratings of pain. Positive effects were seen on depression,
ital exhaustion and stress behaviour. The effects of therapy were
aintained and enhanced during the follow up period. It appears
hat women with FMS  after the CBT treatment, according to this
rotocol obtained tools leading to better acceptance of their disor-
er.
. Implications
FMS  is disorder with great therapeutic challenges. Given that
otal abolishment of pain symptoms is extremely difﬁcult or impos-
ible to achieve, interventions should focus on the effects of pain
n daily function and quality of life, and thereby give the patients
ore satisfaction and possibly a reduction of the pain experience.
hus, the development of individual strategies for coping with
ain is essential to reduce its impact on daily life. In order to
chieve increased self-efﬁcacy and sense of internal control over
ne’s life, the individual’s own motivation (reason and need) for
hange should be an important target for intervention. Since stress
ay  worsen the pain experience, coping with stress might be a
romising route to accomplishing that goal. The stress manage-
ent CBT programme in this study has proven to be a valuable tool
or enhanced life quality in spite of pain.
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Appendix. Cognitive behaviour therapy in women with
ﬁbromyalgia
Stress and pain management intervention programme treatment
format
The intervention consisted of twenty CBT sessions during a
six-month period. The women  were allocated into treatment sub-
groups with 5–7 women  in each. The programme offered 20
three-hour sessions over the course of 6 months. When the 20
sessions were completed, three CBT group booster sessions were
given, each with three hours’ duration during the next six months.
Two psychologists trained in CBT provided the treatment. Supervi-
sion was  given by one of the authors (GB).
The overall goal of the treatment was  to develop emotional and
behavioural coping strategies for dealing with stress. The focus was
particularly on stress reactivity and stress behaviours character-
ized by negative affect like hostility, anxiety, and depressive mood
reactions.
Treatment goals and methods
There were six key components of the programme with speciﬁc
goals.
Education: The goal was  to develop knowledge about basic
anatomy and physiology of the pain and stress processing sys-
tems; manifestations of and treatment procedures for pain and
stress; emotional consequences of stress; health behaviours and
lifestyle; symptoms and signs of stress reactions; and the rela-
tionship between pain, stress and general wellbeing. The session
agendas contained discussion of case illustrations, and use of slide
presentations, written, audio- and videotaped material.
Self-monitoring: The goal was to become more alert to body
signals, such as muscular tension, heart rate, and pain, noticing
behavioural and cognitive cues, observing, reﬂecting, and drawing
conclusions about contingencies of behaviour. This was  achieved
by observing and monitoring own reactions and behaviours by use
of ‘diaries’, systematic observation of speciﬁc behaviours, and use of
group processes to enhance observational skills and understanding.Skills training: The goal was to reduce negative affect and learn
to act constructively, rather than merely react, to everyday prob-
lems of life. In order to develop behavioural skills as alternatives
to anger, frustration, and depressive reactions, a ‘drill book’ was
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sed for daily behavioural exercises. Problem solving and commu-
ication skills were practiced in and outside the group. The group
ormat was important in setting the stage for modelling and group
rocesses as an arena for development of coping skills.
Cognitive restructuring: The goal was to be able to recognize neg-
tive, hostile, and stress-triggering cognitions and attitudes, and to
evelop self-talk to reduce stress reactivity. A special focus was
n hostility, worries, and self-defeating attitudes. Ways to achieve
his goal was to use group discussions to review attitudes and
eliefs, self-monitoring of thoughts, attitudes, and interpretations
hat were evoked by skills training and everyday life experiences,
estructuring of attribution styles, and development of speciﬁc cog-
itive techniques.
Life value issues: The treatment included group discussions
elated to quality of life issues, such as basic values and what well-
eing meant in each participant’s personal life. This could refer
o the meaning of relationships and signiﬁcant others, work or
ctivity, health, future, positive emotions. The purpose of these
iscussions was to evoke the women’s long-term commitment to
nd motivation for change. The social and emotional support of the
roup was instrumental for the development of self-esteem and
ptimism.
Relaxation. Jacobsen’s progressive relaxation was practiced for a
ew minutes during each session, and the participants were encour-
ged to apply the relaxation skill to relevant situations in everyday
ife.
ationale and structure
The structure of the programme was similar to most cognitive-
ehavioural treatment programmes. Each session had an agenda
nd a speciﬁc theme. The session started with a few minutes of pro-
ressive muscular relaxation. Next, homework assignments were
eviewed and reﬂected upon. The current theme was  discussed and
laborated, and new themes and issues were introduced, building
n previous discussions. The session ended with agreements on
ontinued or new homework assignments that were mostly shared
y all group members, and sometimes individually tailored. A vari-
ty of educational material was used, such as case illustrations,
eadings, working material, slides and ﬁlms, and handouts. Diaries
ere used throughout the treatment period, as well as a booklet
ith daily behavioural exercises.
Within the structure of the programme, the speciﬁc contents
nd themes were tailored to particular and typical daily life expe-
iences of men  and women, respectively. The examples from and
pplications to daily life experiences were solicited through self-
onitoring diaries. For the women, skills training needed to focus
n self-conﬁdence and self-assertion, while in contrast, many men
ith CHD in these groups needed to develop skills to cope with
ggressive and hostile behaviour. Another example of how focus
ould differ for men  and women in the groups was the role of the
ocial network. Many women were over-involved in social ties to
he point where their own needs were subdued, while social net-
ork for most men  provided unconditional support. Also, when
ealing with the issue of anger and hostility, the triggers as well
s the expression of such affect generally differed between the
en  and the women, reﬂecting the gender roles. Therefore, single-
ender groups provided shared experiences and good mutual
nderstanding between the participants, thus enhancing therapeu-
ic efﬁciency.eferences
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